🔎 Trials Near Me

Domov › Rak pljuč › Indiana › Indianapolis

Klinične študije za Rak pljuč v Indianapolis, IN

16 študij za Rak pljuč išče udeležence na lokacijah v Indianapolis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Vključevanje udeležencevFaza 3
  • Saint Catherine Hospital, Indianapolis
Starost 70 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • Saint Catherine Hospital, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04267848

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Vključevanje udeležencevFaza 3
  • Saint Catherine Hospital, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Vključevanje udeležencevFaza 3
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
  • IU Health West Hospital, Avon · 13 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06625775

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Community Health Network, Inc, Indianapolis
  • Community Health Network, Inc., Indianapolis
  • Community Health Network, Inc., Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07222566

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Vključevanje udeležencevFaza 2/3
  • Indiana University Health University Hospital, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Vključevanje udeležencevFaza 1/2
  • Community Health Network, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

Increasing Equity in Lung Cancer Screening

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Eskenazi Health, Indianapolis
Starost 50–80 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06360822

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • Community Cancer Center North, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Vključevanje udeležencevOpazovalna študija
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Roudebush VA Medical Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT05889546

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Vključevanje udeležencevFaza 1/2
  • University of Indiana, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 14. maj 2026 · NCT06922591

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
  • Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 8. apr. 2026 · NCT04919382

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Vključevanje udeležencev
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Starost 18 in več · Vsi spoli · Posodobljeno 19. feb. 2026 · NCT02984761

Študije za Rak pljuč v drugih mestih

Druge študije v Indianapolis

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.